Effects of oral administration of Lactobacillus acidophilus l-92 on the symptoms and serum markers of atopic dermatitis in children

International Archives of Allergy and Immunology

Volumn 154, Issue 3, 2011, Pages 236-245

  Torii, Shinpei ^a   Torii, Akiko ^b   Itoh, Komei ^c   Urisu, Atsuo ^d   Terada, Akihiko ^e   Fujisawa, Takao ^g   Yamada, Kazue ^f   Suzuki, Hiromi ^h   Ishida, Yu ^h   Nakamura, Futoshi ^h   Kanzato, Hiroki ^h   Sawada, Daisuke ^h   Nonaka, Atsuko ^h   Hatanaka, Misaki ^h   Fujiwara, Shigeru ^h  

^a Kamiiida Daiichi General Hospital   (Japan)

^b AICHI GAKUSEN UNIVERSITY   (Japan)

^c AICHI CHILDREN'S HEALTH AND MEDICAL CENTER   (Japan)

^d FUJITA HEALTH UNIVERSITY   (Japan)

^e Daido Hospital   (Japan)

^f Yamada Clinics   (Japan)

^g MIE NATIONAL HOSPITAL   (Japan)

^h CALPIS Co Ltd   (Japan)

Author keywords

Atopic dermatitis; Biogenics; Children; Lactobacillus acidophilus L 92; Probiotics

Indexed keywords

PROBIOTIC AGENT; STEROID; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ADOLESCENT; ARTICLE; ATOPIC DERMATITIS; BLOOD EXAMINATION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FECES MICROFLORA; FEMALE; HUMAN; LACTOBACILLUS ACIDOPHILUS; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADMINISTRATION, ORAL; ADOLESCENT; BACTEROIDACEAE; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; COLONY COUNT, MICROBIAL; DERMATITIS, ATOPIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFANT; INTESTINES; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; MALE; PROBIOTICS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77956844827     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321110     Document Type: Article

References (39)

1. Fuller R: Probiotics in man and animals. J Appl Bacteriol 1989; 66: 365-378.
2. Fuller R: Probiotics in human medicine. Gut 1991; 32: 439-442.
3. Mitsuoka T: Significance of dietary modification of intestinal flora and intestinal environment. Biosci Microflora 2000; 19: 15-25.
4. Williams H, Robertson C, Stewart A, Aït-Khaled N, Anabwani G, Anderson R, Asher I, Beasley R, Björkstén B, Burr M, Clayton T, Crane J, Ellwood P, Keil U, Lai C, Mallol J, Martinez F, Mitchell E, Montefort S, Pearce N, Shah j, Sibbald B, Strachan D, von Mutius E, Weiland SK: Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999; 103: 125-138. (Pubitemid 29063202)
5. Cork MJ, Robinson DA, Vasilopoulos Y, Ferguson A, Moustafa M, MacGowan A, Duff GW, Ward SJ, Tazi-Ahnini R: New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol 2006; 118: 3-21. (Pubitemid 43946484)
6. Leung DY, Bogniewicz M, Howell MD, Nomura I, Hamid QA: New insights into atopic dermatitis. J Clin Invest 2004; 113: 651-657. (Pubitemid 38544154)
7. Vickers CFH: The natural history of atopic eczema. Acta Derm Venereol 1980; 92: 113-115.
8. Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E: Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet 2001; 357: 1076-1079. (Pubitemid 32322538)
9. Strachan DP: Hay fever, hygiene, and household size. BMJ 1989; 299: 1259-1260.
10. Betsi GI, Papadavid E, Falagas ME: Probiotics for the treatment or prevention of atopic dermatitis: a review of the evidence from randomized controlled trials. Am J Clin Dermatol 2008; 9: 93-103. (Pubitemid 351280953)
11. Brouwer ML, Wolt-Plompen SA, Dubois AE, van der Heide S, Jansen DF, Hoijer MA, Kauffmann HF, Duiverman EJ: No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy 2006; 36: 899-906. (Pubitemid 43972956)
12. Ishida Y, Nakamura F, Kanzato H, Sawada D, Yamamoto N, Kagata H, Oh-ida M, Takeuchi H, Fujiwara S: Effect of milk fermented with Lactobacillus acidophilus strain L-92 on symptoms of Japanese cedar pollen allergy: a randomized placebo-controlled trial. Biosci Biotechnol Biochem 2005; 69: 1652-1660.
13. Ishida Y, Nakamura F, Kanzato H, Sawada D, Hirata H, Nishimura A, Kajimoto O, Fujiwara S: Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis: a double-blind, placebo-controlled study. J Dairy Sci 2005; 88: 527-533.
14. Torii A, Torii S, Fujiwara S, Tanaka H, Inagaki N, Nagai H: Lactobacillus acidophilus strain L-92 regulates the production of Th1 cytokine as well as Th2 cytokines. Allergol Int 2007; 56: 293-301.
15. Kanzato H, Fujiwara S, Ise W, Kaminogawa S, Sato R, Hachimura S: Lactobacillus acidophilus strain L-92 induces apoptosis of antigen-stimulated T cells by modulation dendritic cell function. Immunobiology 2008; 213: 399-408.
16. Hansen G, McIntire JJ, Yeung VP, Berry G, Thornbecke GJ, Chen L, DeKruyff RH, Umetsu DT: CD4(+) T helper cells engineered to produce latent TGF-β1 reverse allergen-induced airway hyperreactivity and inflammation. J Clin Invest 2000; 105: 61-70. (Pubitemid 30036388)
17. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y: The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997; 159: 1739-1745. (Pubitemid 127484159)
18. Bahmer FA: ADASI score: atopic dermatitis area and severity index. Acta Derm Venereol Suppl (Stockh) 1992; 176: 32-33.
19. Saeki H, Furue M, Furukawa F, Hide M, Ohtsuki M, Katayama I, Sasaki R, Suto H, Takehara K; Committee for Guidelines for the Management of Atopic Dermatitis of Japanese Dermatological Association: Guidelines for management of atopic dermatitis. J Dermatol 2009; 36: 563-577.
20. Mitsuoka T, Hayakawa K: Die Faekalflora bei Menschen. I, Mitteilung; Die Zusammensetzung der Faekalflora der verschiedenen Altersgruppen. Zbl Bakt Hyg I Orig A 1972; 233: 333-342.
21. Mitsuoka T, Hayakawa Y, Kimura N: Die Faekalflora bei Menschen, II, Mitteilung; Die Zusammensetzung der Bifidobacterienflora der verschiedenen Altersgruppen. Zbl Bakt Hyg I Orig A 1974; 226: 469-478.
22. Mitsuoka T, Hayakawa Y, Kimura N: Die Faekalflora bei Menschen, III, Mitteilung; Die Zusammensetzung der Laktobazillenflora der verschiedenen Altersgruppen. Zbl Bakt Hyg I Orig A 1975; 232: 499-511.
23. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, Goudie DR, Sandilands A, Campbell LE, Smith FJ, O'Regan GM, Watson RM, Cecil JE, Bale SJ, Compton JG, DiGiovanna JJ, Fleckman P, Lewis-Jones S, Arseculeratne G, Sergeant A, Munro CS, El Houate B, McElreavey K, Halkjaer LB, Bisgaard H, Mukhopadhyay S, Mclean WH: Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38: 441-446.
24. Hoffjan S, Epplen JT: The genetics of atopic dermatitis: recent findings and future options. J Mol Med 2005; 83: 682-692. (Pubitemid 41225110)
25. Novak N, Bieber T, Leung DY: Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 2003; 112:S128-S139. (Pubitemid 37550029)
26. Novak N, Bieber T: Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol 2003; 112: 252-262. (Pubitemid 36981361)
27. Halbert AR, Weston WL, Morelli JG: Atopic dermatitis: is it an allergic disease? J Am Acad Dermatol 1995; 33: 1008-1018.
28. Terada A, Bukawa W, Kan T, Mitsuoka T: Effects of the consumption of heat-killed Enterococcus faecalis EC-12 preparation on microbiota and metabolic activity of the faeces in healthy adults. Microbial Ecol Health Dis 2004; 16: 188-194.
29. Tsukahara T, Bukawa W, Kan T, Ushida K: Effect of a cell preparation of Enterococcus faecalis strain EC-12 on digesta flow and recovery from constipation in a pig model and human subjects. Microbial Ecol Health Dis 2005; 17: 107-113.
30. Caffarelli C, Cavagni G, Deliu F, Zanotti P, Atherton D: Gastrointestinal symptoms in atopic eczema. Arch Dis Child 1998; 78: 230-234. (Pubitemid 28176333)
31. Medina C, Santana A, Liopis M, Paz-Cabrera MC, Antolin M, Quintero E, Malagelada JR: Induction of colonic transmural inflammation by Bacteroides fragilis : implication of matrix metalloproteinases. Inflamm Bowel Dis 2005; 11: 99-105.
32. Breeling JL, Onderdonk AB, Cisneros RL, Kasper DL: Bacteroides vulgatus outer membrane antigens associated with carrageenan-induced colitis in guinea pigs. Infect Immun 1998; 56: 1754-1759.
33. Saeki H, Tamaki K: Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases. J Dermatol Sci 2006; 43: 75-84. (Pubitemid 44094007)
34. Hijnen D, De Bruin-Weller M, Oosting B, Lebre C, De Jong E, Bruijnzeel-Koomen C, Knol E: Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol 2004; 113: 334-340. (Pubitemid 38210559)
35. Jahnz-Rozyk K, Targowski T, Paluchowska E, Owczarek W, Kucharczyk A: Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy 2005; 60: 685-688. (Pubitemid 40562477)
36. Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, Torii H, Asahina A, Onai N, Matsushima K, Tamaki K: Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001; 107: 535-541. (Pubitemid 32210037)
37. Smits HH, Engering A, van der Kleij D, de Jong EC, Schipper K, van Cappel TM, Zaat BA, Yazdanbakhsh M, Wierenga EA, van Kooyk Y, Kapsenberg ML: Selective probiotic bacteria induce IL-10-proucing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intracellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 2005; 115: 1260-1267. (Pubitemid 40824599)
38. Infante-Duarte C, Horton HF, Byrne MC, Kamradt T: Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol 2000; 165: 6107-6115.
39. Nakae S, Saijo S, Horai R, Sudo K, Mori S, Iwakura Y: IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc Natl Acad Sci USA 2003; 100: 5986-5990. (Pubitemid 36576918)